Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997? - Wikidata - awgldk - TriplyDB

Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997?

Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997?

http://www.wikidata.org/entity/Q41552550

about

HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression.Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications.Medical treatment of diabetic retinopathy.Hypertensive retinopathy revisited: some answers, more questions.Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection Management of retinal vein occlusion--consensus document.Plasma total homocysteine and retinal vascular disease.

P2860

Q24682714-3348B37A-EAD8-4031-A607-D5418606BACA Q27489101-CE0489DC-A155-4FDF-B309-7C7D93AC29AD Q27620356-FB9F3648-8F3A-4989-98E5-A39E2026A9CE Q28344746-50C5CB94-9954-48D8-8A8E-83637FF364A6 Q35114369-1A7E0B9F-424D-4734-9DB4-0AFFB10AB5EA Q35132239-B9D8B43A-2FE4-42A6-AB96-4D3D557DA8BA Q35175679-B5E5C235-BA2A-44D5-9E7A-22D12D1670E3 Q35594054-425267E0-17DB-46A0-BAC5-3912F1D7C257 Q35886502-7665720A-EF33-4952-8DA1-751FDE65632F Q36828663-C225BDA7-BF36-4655-9715-C8001D76CFF3 Q37876127-5D339744-C081-4B7E-A427-A815094996E1 Q51553093-1EC8429E-5E35-4B54-9F5A-A8A19FA08F5F

P2860

Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997?

http://www.wikidata.org/entity/Q41552550

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997?

@en

type

label

Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997?

@en

prefLabel

Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997?

@en

P1433

Q41552550-EAC229A4-E516-45E0-8DD7-1E27FC73D559

P1476

Q41552550-DD034322-E857-4686-B30F-D2939F2A184E

P2093

Q41552550-5A0E4DD8-6009-4836-B006-821FB6020C76

Q41552550-BB6FD9BE-4B33-4998-BB68-2DDB66D37E3B

P2860

Q41552550-01E985E6-A71E-4F86-87FB-54279EBF6896

Q41552550-0499E894-E6BB-4487-9483-05225E6D0917

Q41552550-04DF25B9-D044-4A76-97B2-E9E4BE45B8E1

Q41552550-0B39EDE2-4AE2-41FB-B7C8-EB362638186B

Q41552550-0E17800C-EB5B-469E-B50F-C9349EC2D199

Q41552550-10670DB5-3C74-48C3-B631-04A5DCB47118

Q41552550-1355CDDB-2956-4AC1-9FB9-DBBA280A99AE

Q41552550-13B23B03-685D-44EA-96F5-19C949F6E5DC

Q41552550-1697C52F-62F2-4A75-9151-D0ED485187C9

Q41552550-3A50C23D-A71F-4455-8CFE-11687DAB0109

P2888

Q41552550-20A719EF-4B2A-471A-AB93-B4C4D2EE5859

P304

Q41552550-24202F1E-00D3-4511-8D43-B8A45523A7BD

P31

Q41552550-38F6ED2E-9C39-46B2-A4B7-C0EC8193058A

P356

Q41552550-662E7192-5364-4260-8240-BEA4D1C2ED34

P478

Q41552550-33FB1E5A-A8A4-4505-9AC6-DD442224E7E4

P577

Q41552550-C7A8E9BF-7F98-4AEC-92A2-D7DB7CC1F0F5

P5875

Q41552550-EA0C1B8E-0695-4AE8-9BDA-1A60458879EF

P6179

Q41552550-35E30EF7-9447-458F-A702-B2C6A7F8AF5B

P698

Q41552550-23CD1C46-0F87-46BF-A1F0-DF36F4BE5323

P356

P1433

P1476

Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997?

@en

P2093

Dodson PM

http://www.w3.org/2001/XMLSchema#string

Kritzinger EE

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Prognosis of patients with retinal embolism

Medical conditions underlying recurrence of retinal vein occlusion.

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.

Prognosis and prognostic factors of retinal infarction: a prospective cohort study

Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.

P2888

P304

3-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EYE.1997.2

http://www.w3.org/2001/XMLSchema#string

P478

11 ( Pt 1)

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13974190

http://www.w3.org/2001/XMLSchema#string

P6179

1000564927

http://www.w3.org/2001/XMLSchema#string

P698

9246268

http://www.w3.org/2001/XMLSchema#string